Modified Hepatic Arterial Infusion Chemotherapy Combined with Lenvatinib and Camrelizumab for Advanced HCC: Two Case Reports

BACKGROUND: Advanced-stage hepatocellular carcinoma (HCC), especially huge HCC or portal vein tumour thrombus (PVTT), is difficult to treat, and the prognosis is poor. The advantages of hepatic artery infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy for this complex dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Yuan, Jin, Wenbiao, Sun, Honghua, Jin, Dehao, Kang, Dongxu, Li, Zhiyu, Piao, Longzhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542216/
https://www.ncbi.nlm.nih.gov/pubmed/37791067
http://dx.doi.org/10.2147/JHC.S426174

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542216/
https://www.ncbi.nlm.nih.gov/pubmed/37791067
http://dx.doi.org/10.2147/JHC.S426174

Ejemplares similares